November 6, 2025 by
If you’ve ever tried getting someone with Alzheimer’s ready for a doctor’s appointment, you know it’s rarely as simple as “let’s go.” There are layers of stress: convincing them to put on a coat, handling confusion about why they’re leaving the house, navigating anxiety in the car, and then bracing for the unfamiliar chaos of waiting rooms and fluorescent lights. What should be a simple trip can feel like climbing a mountain.
That’s why the FDA’s approval of at-home Leqembi® injections is so groundbreaking. It’s truly a game changer, bringing new hope in Alzheimer’s care.
What Is Leqembi?
Leqembi (lecanemab-irmb) is an anti-amyloid therapy designed to target and clear amyloid beta proteins in the brain, the harmful clumps linked to memory decline and confusion in Alzheimer’s disease.
Originally approved in 2023, Leqembi had to be given as an intravenous (IV) infusion every two weeks at a hospital or infusion center. That meant constant outings, transportation logistics, and time lost to medical settings.
Now, after an initial infusion period, eligible individuals can switch to a weekly at-home injection with a simple autoinjector device that delivers the dose in just 15 seconds. No waiting rooms. No car rides. No disruption to a familiar daily routine.
Why It Matters
Research showed that Leqembi slowed cognitive decline by about 27% over 18 months compared to a placebo. Nearly half of the participants even cleared amyloid plaques on brain imaging. While Alzheimer’s still has no cure, this therapy offers something invaluable: more time.
The new at-home injection option means:
- Less disruption: No stressful medical outings every couple of weeks.
- More comfort: Treatment happens in familiar surroundings, where the person feels secure.
- More quality time: Treatments are complete in seconds instead of the hours devoted to in-clinic infusions.
- More hope: Even slowing decline slightly means preserving cherished connections for longer.
The Challenge of Medical Outings
Anyone who has walked this road knows that a trip to the doctor with someone who has Alzheimer’s is more than a logistical task. It can throw off the entire day.
- Breaking routines: Alzheimer’s thrives on routine, and leaving home can cause confusion or agitation.
- Overstimulation: Bright lights, crowded waiting areas, and long waits can trigger anxiety or even behavioral outbursts.
- Exhaustion: What feels like a short appointment to most can be mentally and physically draining for someone with dementia.
Alzheimer’s Care Is Moving Home
The move to at-home Leqembi injections is part of a larger trend: health care is coming home. And for families facing Alzheimer’s, this change can be life-changing.
With At Home Independent Living, we see this principle every day. Just as medical treatments like Leqembi are making care more accessible and less disruptive, our in-home dementia care services allow families to keep routines intact and preserve familiar surroundings. A calm evening, a favorite story, or a shared laugh…these are the moments worth protecting.
Looking Ahead
Alzheimer’s remains one of the toughest diagnoses a family can face. The journey is still uncertain, but each new step in treatment matters. The approval of at-home Leqembi injections marks a hopeful shift, not only because of the medical benefits, but because it respects the everyday realities of caregiving.
Finding Additional Support at Home
Medical innovations like Leqembi open new doors, but they don’t replace the daily care and companionship that those with dementia need to thrive at home. At Home Independent Living brings specialized dementia care into the home, supporting families in Syracuse, Camillus, Clay, and throughout Central New York.
If someone you love is living with Alzheimer’s, call us at (315) 579-HOME (4663). Together, we can help you navigate both the breakthroughs and the everyday challenges of care, while making each day the best it can be for the person you love.